Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops (NIH) Fetalis by Massively Parallel Sequencing

NACompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

April 12, 2021

Primary Completion Date

April 12, 2024

Study Completion Date

April 12, 2024

Conditions
Non-Immune Hydrops Fetalis
Interventions
DIAGNOSTIC_TEST

NON-IMMUNE HYDROPS FETALIS diagnosis

Amniotic liquid of each selected patients will be tested by both technic to describe and detect etiological information. Each patient will be tested using the current procedure with a defined panel of genes as well as with the NGS procedure. The results of both procedures will be compared.

Trial Locations (17)

13000

Hopital Nord, Marseille

13005

CHU Marseille Timone, Marseille

21079

Hôpital Le Bocage, Dijon

31059

Hôpital Paule de Viguier;, Toulouse

33076

CHU Pellegrin, Bordeaux

34295

CHU Montpellier, Montpellier

38700

CHU Grenoble, La Tronche

42270

CHU Saint Etienne, Saint-Priest-en-Jarez

54511

CHU de Nancy Brabois,, Vandœuvre-lès-Nancy

63003

Hôpital d'Estaing, Clermont-Ferrand

69004

Hopital Croix Rousse, Lyon

69310

Hopital Lyon Sud, Pierre-Bénite

69500

Hôpital Femme Mère Enfant, Bron

75012

APHP Trousseau, Paris

87042

CHU Limoges, Limoges

25000 Besancon

CHU Besançon, Besançon

06200

Hôpital Archet 2, Nice

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER